Edit Content

International Advanced Medical Therapies Conference V3 Schedule Live simultaneous interpretation willbe provided for allspeeches in English, Thai, or other required languages (pre-registration is essential).

We are the World Global Summit on Advanced Medical Therapies, Al and TCM

November 9 to 11, 2025 QSNCC Convention Center, Bangkok
AGENDA WITH DETAILED SPEAKER SESSIONS
Day 1- November 9, 2025 (Sunday)

MORNING SESSION

10:00-12:00 Grand Opening Ceremony
Grand Opening Ceremony
Conference Language Services
Real-time simultaneous interpretation in English, Thai, and multiple languages will be provided (advance registration required).
Feature & Speaker Info
Track 1A: Breakthroughs in Gene Therapy
Q & A: 30 minutes included for panel discussion and audience questions.
Track 1B: Latest Advanced Medical Technologies and Clinical Trial Outcomes for "Cancer"
Q & A: 30 minutes included.
Track 2C: World-Renowned Clinical Professors Share Anti-Aging, Natural Therapies, Sleep Solutions, and the Latest Advanced Medical Technologies and Clinical Trial Outcomes
Q & A: 30 minutes included.

AFTERNOON PARALLEL TRACKS

14:00-17:30 (Choose One Track per Time Slot)

Track 1A: Breakthroughs in Gene Therapy for different diseases

Professor Zhang Weiwei (American Chinese)
  • Founding figure in international gene therapy.
  • Developer of the world’s first commercial gene therapy drug, “P53 Gendicine.
  • 30 years of experience in gene drug R&D.
  • Research endorsed by multiple Nobel laureate.
  • Willaddress challenges in tumor gene therapy and share clinical case studies.
Professor Wei Qingyi (American Chinese)
  • Pioneer in molecular cancer epidemiology.
  • Leading authority in DNA repair mechanisms.
  • Tenured professor at MD Anderson Cancer Center.
  • Groundbreaking research underpins cancer prevention and precision treatment.
  • Will present latest research outcomes and clinical trial results.
Dr. Marcelo Lam (American Chinese)
  •  International leader in integrative oncology.
  • Pioneer in artemisinin-based cancer applications.
  • Founder of TCM Physicians, a world-class integrative oncology center.
  • 20 years of clinical experience.
  • Will share successful cases of integrated Chinese-Western cancer treatments and clinical data.
Professor Xiao Xiao (American Chinese)
  • Internationally recognized pioneer in hemophilia gene therapy.
  • Authority in AAV vector technology.
  • Developed China’s first hemophilia gene drug to enter clinical trials.
  • Set new standards in the field with breakthrough breakth research
  • Will present latest advances in gene therapy and clinical applications.
Professor Han Zhongchao (French-Chinese)
  • Member of the French National Academy of Medicine and National Academy of Technologies.
  • Recipient of the National Science and Technology Award.
  • Established China’s first National Stem Cell Engineering Technology Research Center.
  • Recognized as a “Highly Cited Chinese Researcher” for ten consecutive years.
  • Will share innovations in placental stem cell technology, CAR-NK cell therapy, and clinical
    translation achievements.

Topic 1B: Latest Advanced Medical Technologies and Clinical Trial Outcomes for Cancer

Professor Xu Kecheng (China)
  • Founder of cryotherapy in China
  • Recipient of the Bethune Medal
  • Founder of Fuda Cancer Hospital
  • Innovatively integrated seven FDA-approved bacterial strains with integrative immunotherapies
  • Treated nearly 100,000 cancer patients over decades
  • Will share insights on composite immune regulation and clinical case studies
Professor Li Dinggang (China)
  • Mayo Clinic-certified international referral specialist
  • Chief Clinical Medical Expert at the Southern University of Science and Technology Cell
    and Gene Therapy Research Center
  • Pioneer in oncological gene therapy and international diagnosis
  • Will share global cancer treatment options, cross-border medical channels, and clinical trial
    outcomes
Professor Zhang Minghui (China)
  • Pioneer of vNKT cell therapy at Tsinghua University
  • Treated nearly 1,000 cases from 2010–2025
  • Achieved 90% 5-year tumor-free survival for Stage III cancer, 80% remission for Stage IV,
    and 20% clinical cure for advanced metastatic cancer
  • Covered 15+ solid tumors including liver, lung, pancreatic, and breast cancers
  • Will present clinical outcomes and research data
Professor Yu Baofa (Canada Chinese)
  • Inventor of Sustained-Release Library Therapy
  • Foreign Academician of the Russian Academy of Natural Sciences
  • UMIPIC® technology treated nearly 100,000 cases over 27 years with 95% efficacy
  • Recognized by international guidelines and collaborated with Nobel laureates
  • Will explain principles and applications of UMIPIC® technology with clinical evidence
Professor Fan Yufei (China)
  • Pioneer in non-invasive tumor therapy
  • Leader in China’s HIFU technology
  • Treated over 1,000 cases of malignant solid tumors
  • Distinguished clinical medical expert
  • Will share classic cases of non-invasive treatment

Track 2B: Latest Advanced Medical Technologies and Clinical Trial Outcomes for Parkinson's, Alzheimer's, Diabetes, and Autism

Dr. Wang Taihua (Canadian-Chinese)
  • Internationally recognized authority in neural stem cell transplantation.
  • Founder of Ser Group.
  • Completed 5-year clinical safety verification of stem cell therapies.
  • Published extensively in international journals.
  • 25 years of clinical experience, treated over 100,000 cases.
  • Will share outcomes in stem cell therapy for Parkinson’s and Alzheimer’s
Professor Huang Wenlin (American - chinese)
  • Founding figure in gene therapy in China.
  • Developer of the first gene drug.
  • Academician of the European Academy of Sciences.
  • 40 years as a clinical professor, treated over 100,000 cases.
  • Triple mechanism: repairs pancreatic ẞ-cells, improves insulin resistance, reduces complications.
  • Phase I clinical trials show significant hypoglycemic and anti-inflammatory effects.
  • Limited complimentary treatment slots available-applications welcome
Professor Liu Baochi (China)
  • Pioneer in HIV surgery and cell therapy.
  • Performed 2,000 HIV surgeries.
  • Developed autologous bone marrow cell therapy for liver cirrhosis, diabetes, and degenerative diseases.
  • Director of Surgery at Shanghai Public Health Clinical Center.
  • Will share cutting-edge solutions for HIV treatment.
Dato' Sri Professor Chen Gecheng (Malaysia)
  • International authority in stem cells and regenerative medicine.
  • 40 years of clinical and research experience.
  • Founded the world’s first stem cell association.
  • Leads 46 international medical institutions.
  • Holds 50 patents, authored 60+ books.
  • Published extensively on autism biological treatments.
  • Will share breakthroughs in stem cell interventions for autism.

Track 2C: Anti-Aging, Natural Therapies, and Sleep Solutions

Dr. Claude Chauchard (France)
  • National treasure-level authority in anti-aging medicine in France.
  • 35 years of clinical experience, former health advisor to Princess Diana.
  • Introduced anti-aging medicine to Asia in 1993.
  • Focuses on gene editing, stem cells, and Al in longevity medicine.
  • Will share breakthrough anti-aging technologies for the next 5-10 years.
Dr. Paul Rochon (France)
  • Authority in sleep, hypnosis, and cognitive science.
  • Ph.D. in Neuroscience and Psychology.
  • Director of the Sleep Center at Belijing Raffles Hospital.
  • Certified American hypnotherapy expert.
  • 20+ years of cross-cultural clinical practice.
  • Will introduce scientifically validated sleep improvement methods.
Anthony Fulker (Canada)
  • Practitioner promoting natural and holistic health concept.
  • Guides individuals to harness the body’s self-healing power using natural laws.
  • Helps rebuild autonomous health management capabilities.
  • Will present a health awakening course for modern lifestyles
Note: The agenda is subject to minor adjustments. Please refer to on-site announcements for final details. For more speaker information, visit the official website’s feature section.

International Summit Opening Ceremony Founders, Organizer and Distinguished Guests List

Dr. Adrian Cheng

Founder of K11 & ALMAD Group | Chairman of Hong Kong Mega Arts & Cultural Events Committee | Chairman of The Hong Kong Academy of Wealth Legacy | Scion of the Chow Tai Fook Family

Mr. Michael Chin
Co-Founder & Executive Chairman of GTGL & WTGHI Groups | Global Hotel Investment Expert | Pioneer in Transnational Health Industry
Ms. Josephine Ko
Co-Founder of GTGL & WTGHI Groups | International Cross-Border Brand Builder | Pioneer in Transnational Health Industry

Guest of Honour Speakers

H.E. Phinij Jarusombat
Former Deputy Prime Minister & Minister of Public Health of Thailand | Chairman of Thai-Chinese Culture Promotion Committee | Vice President of International Confucian Association
Dr. Lijin Yan
Executive Vice Chairman of Traditional Chinese Medicine Culture Congress | Chairman of Silk Road Group | Member of UN Trade and Development BODR Strategic Steering Committee
Congress Chairman
Mr. Michael Chin
Executive Chairman of GTGL & WTGHI Groups | Pioneer in Transnational Health Industry
Thailand Co-Organizers
Khun Sorapoj Techakraisri
Founder of Thailand’s PACE Development | Prominent Real Estate Development Leader
Dr. Bhichit Rattakul, PhD
Former Governor of Bangkok | Senior Public Affairs Leader
Khun Sranyoo Chanate
CEO of Kluaynamthai General Hospital | Vice President of Kluaynamthai Hospital Group

Keynote Speakers

Dr. Yao Yi
Recipient of 2017 FDA Lifetime Achievement Award | Strategy Architect in Cell & Gene Therapy | Visiting Professor at Multiple Prestigious Universities & Hospitals
Prof. Xu Kecheng
Lifetime Honorary President of International Society of Cryosurgery | Recipient of Norman Bethune Award | Founder of Fuda Tumor Hospital
Prof. Wen-lin Huang
Academician of European Academy of Sciences | Pioneer in Gene Therapy | Leader in Developing China’s First Gene Therapy Drug E10A
Prof. Zhongchao Han
Academician of French National Academy of Medicine & Academy of Technologies | Authority in Stem Cells & Hematology | Chairman of Chinese Stem Cell Group

Daily Program Schedule

Hour-by-hour breakdown of activities

April 15

08:00 – 17:00

08:00 – 17:00

April 16

08:00 – 18:00

08:00 – 18:00

April 17

09:00-17:00

09:00-18:00

April 18

08:00 – 17:00

08:00 – 17:00

April 19

08:00 – 18:00

08:00 – 18:00

April 20

09:00-17:00

09:00-18:00

Global Health Revolution: Driving Change Through Innovation

This program examines the dynamic evolution of global healthcare systems through the lens of cutting-edge innovation and progressive policy. With rapid breakthroughs in telemedicine, artificial intelligence, and precision medicine reshaping the landscape, our expert speakers—from visionary entrepreneurs to seasoned policymakers—will explore how these transformative technologies are redefining healthcare delivery worldwide. Participants will dive into detailed case studies that highlight successful integrations of new technologies within traditional healthcare systems, emphasizing improved patient outcomes, enhanced efficiency, and cost-effective care. The discussion also addresses regulatory challenges, data security issues, and the need for cross-border collaboration to set global standards.  

Digital Health Frontier: Redefining Patient Care Worldwide

In an era where digital solutions are rewriting the rules of engagement, this program focuses on how telehealth, mobile applications, wearables, and remote monitoring technologies are fundamentally altering patient care. Leading digital health experts and clinicians will discuss the practical implementations of these technologies—from virtual consultations and real-time health tracking to AI-powered diagnostics—and their impact on patient outcomes and healthcare accessibility. Through interactive case studies, participants will learn how digital transformation is reducing disparities, enhancing personalized care, and streamlining operations in healthcare institutions globally.  

Strategies for Sustainable Transformation

Recent global challenges have underscored the urgent need for robust healthcare systems that can withstand and adapt to crises. This session is dedicated to exploring strategies that build resilient infrastructures capable of meeting both current demands and future uncertainties. Experts in public health, emergency response, and healthcare management will share insights on optimizing resource allocation, strengthening supply chains, and implementing risk mitigation protocols.  

Attending the We Are The World summit was a transformative experience. The keynote sessions were inspiring, and the networking opportunities allowed me to connect with industry leaders from around the globe. This event has truly propelled my professional growth.

Jane Doe CEO, Global Innovators

My experience at the We Are The World summit exceeded all expectations. Every session was thoughtfully curated and full of actionable insights. The dynamic atmosphere fostered collaborations that continue to benefit my organization today.

John Smith CTO, Tech Solutions Inc.

I left the summit feeling energized and armed with fresh ideas. The blend of forward-thinking presentations and interactive workshops created an environment where creativity and expertise merged seamlessly. This event is a must-attend for anyone looking to make an impact.

Mary.k Marketing Director, Creative Ventures